About: As of June 11, 2026, Adial Pharmaceuticals, Inc. was acquired by Azora Therapeutics, Inc. Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.05 (-1.10%)
ADIL NASDAQ Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc share price
ADIL price activity
Last Price
$4.050
Change (24hr)
-0.05 USD (1.10%)
Volume
7.04K
Volume (4w avg)
-
Open
$3.95
Day Range
$3.95 - $4.30
Previous Close
$4.10
Last Trade
04 Nov, 2:30 pm GMT+0
Delayed
04 Nov, 2:30 pm GMT+0
ADIL price performance
Delayed
04 Nov, 2:30 pm GMT+0
ADIL details
ADIL Market Signals